咨询与建议

看过本文的还看了

相关文献

该作者的其他文献

文献详情 >MONOCLONAL ANTIBODY 55 (CD10) ... 收藏

MONOCLONAL ANTIBODY 55 (CD10) AND COMPLEMENT USED FOR PURGING AUTOLOGOUS BONE MARROW IN COMMON ACUTE LYMPHOBLASTIC LEUKEMIA

作     者:白炎 朴鲜华 罗庆良 毛秉智 

作者机构:Institute of Basic Medical Sciences Academy of Military Medical Sciences Beijing. 

出 版 物:《中华医学杂志(英文版)》 (Chinese Medical Journal)

年 卷 期:1990年第103卷第5期

页      面:385-390页

核心收录:

学科分类:1002[医学-临床医学] 

摘      要:A CD10 monoclonal antibody 55 (McAb55) was intended for purging residual common acute lymphoblastic leukemia antigen (CALLA) positive leukemic cells from autotransplants of common acute lymphoblastic leukemia (C-ALL) patients. It was found that after two rounds of McAb55 and complement treatment, 4-5 logs of CALLA+ cells were removed from bone marrow detected by clonogenic assay. The standardization of separation, purgation and preservation of bone marrow for C-ALL patients’ autotransplants was then set as follows: Following the carboxymethyl starch sedimentation and Ficoll-Hypaque gradient separation, the isolated mononuclear cells (MNCs) were treated with McAb55 and complement twice and kept in room temperature for 48-72 hours prior to infusion. This procedure resulted in the remoral of more than 99% of CALLA+ cells, recovery of 10-30% MNCs, and leaving the hematopoiesis stem cells intact. After the intensive cytoreductive therapy, 4 patients with C-ALL received the purged autotransplants giving timely recovery of the hemmatopoietic function. The patients were all remaining in remission status for more than 40-250 days so far.

读者评论 与其他读者分享你的观点

用户名:未登录
我的评分